SCHEMBL31295307

SCHEMBL31295307

COc1ccccc1CCCN1CCOC(c2n[nH]c3ccccc23)C1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 3/20 0.44
▸ KCNH2 Q12809 1/20 0.42
▸ DRD2 P14416 2/20 0.42
▸ HTR2B P41595 2/20 0.42
▸ HTR1A P08908 2/20 0.41
▸ DRD4 P21917 1/20 0.41
▸ ADRA1D P25100 1/20 0.41
▸ ADRA1A P35348 1/20 0.41
▸ ADRA1B P35368 1/20 0.41
▸ BCHE P06276 1/20 0.40
▸ CHRNB2 P17787 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ CHRNA7 P36544 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31295205 0.82 CYP2D6 (0.49) SIGMAR1KCNH2HTR1AADRA1D
SCHEMBL31295164 0.76 SSTR4 (0.41) SIGMAR1KCNH2DRD2HTR2BHTR1A
SCHEMBL31295104 0.74 CNR2 (0.48) DRD2DRD4ACHE
SCHEMBL31295077 0.71 CYP2D6 (0.58) HTR1AADRA1D
SCHEMBL23926367 0.71 SIGMAR1 (0.65) SIGMAR1KCNH2DRD2HTR2BHRH3
SCHEMBL30118922 0.71 SIGMAR1 (0.65) SIGMAR1KCNH2DRD2HTR2BHRH3
SCHEMBL31295196 0.68 HTR1A (0.50) HTR1AADRA1D
SCHEMBL7923985 0.67 HRH3 (0.82) SIGMAR1KCNH2DRD2HTR2BHRH3
SCHEMBL31295194 0.66 HTR1A (0.43) SIGMAR1KCNH2DRD2HTR1ADRD4
SCHEMBL9644974 0.66 SIGMAR1 (0.65) SIGMAR1KCNH2DRD2HTR2BHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119698412-A 5-HT2A receptor agonist, and preparation method and application thereof 上海翊石医药科技有限公司 2025-03-25 — — CN disclosed
WO-2025021120-A1 5-HT2A RECEPTOR AGONIST, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翊石医药科技有限公司 2025-01-30 — — WO disclosed
Send feedback